RNA interference against polo-like kinase-1 in advanced non-small cell lung cancers

Worldwide, approximately one and a half million new cases of lung cancer are diagnosed each year, and about 85% of lung cancer are non-small cell lung cancer (NSCLC). As the molecular pathogenesis underlying NSCLC is understood, new molecular targeting agents can be developed. However, current thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawata, Eri, Ashihara, Eishi, Maekawa, Taira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143898/
https://www.ncbi.nlm.nih.gov/pubmed/21884621
http://dx.doi.org/10.1186/2043-9113-1-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143898/
https://www.ncbi.nlm.nih.gov/pubmed/21884621
http://dx.doi.org/10.1186/2043-9113-1-6

Ejemplares similares